Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
The treatment can take effect as soon as 3 to 5 days after the treatment, with the final results becoming visible after about 2 weeks
RCTs should be adequately powered with defined orthopaedic indications
Pre-Blend Dose Assessment (10 units / 0.10 mL daily) Component GHK-Cu Per-dose from Blend ~1.67 mg Typical Standalone 1-2 mg daily Assessment In range Component BPC-157 Per-dose from Blend ~0.33 mg Typical Standalone 0.25-0.5 mg daily Assessment In range Component TB-500 Per-dose from Blend ~0.33 mg Typical Standalone 2-5 mg per injection, 2x/week Assessment Below standalone injury range The 5:1:1 blend is convenience- and skin-focused
This combination product provides investigators with a pre-formulated blend of thymosin beta-4 fragment (TB-500) and Body Protection Compound-157 (BPC-157), enabling studies that examine potential synergistic or additive interactions between these two mechanistically distinct peptide sequences in a single experimental system
Epithalon is never run concurrently with other peptides
US$ 27.30
US$ 24.32
US$ 28.77
US$ 24.49